Document Detail


Bulimia. An underlying behavioral disorder in hyperlipidemic pancreatitis: a prospective multidisciplinary approach.
MedLine Citation:
PMID:  3827458     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Between 1978 and 1985, we conducted a prospective study of 21 patients who survived several attacks of pancreatitis and were diagnosed as having primary hyperlipidemia. None of the patients suffered from chronic alcoholism, primary diabetes, or cholelithiasis or was receiving prolonged steroid therapy. Lowering of plasma lipid values toward normal was achieved in all patients following a program of combined dietary and drug (bezafibrate) therapy. Five patients had recurrent episodes of pancreatitis during the treatment program. These patients were diagnosed subsequently as suffering from bulimia and were all given cognitive behavioral therapy. One patient died following an attack of pancreatitis. An underlying eating disorder should be suspected in patients who relapse after treatment for pancreatitis and hyperlipidemia. Multidisciplinary treatment should be used in these patients to improve therapeutic efficacy and uncover behavioral patterns that have a direct impact on their life expectancy.
Authors:
D Gavish; S Eisenberg; E M Berry; Y Kleinman; E Witztum; J Norman; E Leitersdorf
Related Documents :
2435358 - Diagnostic value of serum elastase 1 in pancreatic disease.
17008278 - The prognostic significance of angiogenesis and the effect of vascular endothelial grow...
1718808 - Lipase/amylase ratio. a new index that distinguishes acute episodes of alcoholic from n...
6975148 - Assessment of exocrine pancreatic function by oral administration of n-benzoyl-l-tyrosy...
3335688 - Amiodarone therapy: role of early and late electrophysiologic studies.
1364038 - Pheochromocytoma in the pregnant patient: a case study.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of internal medicine     Volume:  147     ISSN:  0003-9926     ISO Abbreviation:  Arch. Intern. Med.     Publication Date:  1987 Apr 
Date Detail:
Created Date:  1987-04-22     Completed Date:  1987-04-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372440     Medline TA:  Arch Intern Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  705-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Bezafibrate / therapeutic use
Bulimia / complications*
Cholesterol / blood
Female
Humans
Hyperlipidemias / diet therapy,  drug therapy,  psychology*
Lipoprotein Lipase / blood
Male
Middle Aged
Pancreatitis / etiology*
Prospective Studies
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Triglycerides; 41859-67-0/Bezafibrate; 57-88-5/Cholesterol; EC 3.1.1.34/Lipoprotein Lipase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and fore...
Next Document:  Potassium-lowering effect of albuterol for hyperkalemia in renal failure.